External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Roche and Genentech at

IOIS 2025

June 25 - June 28

Rio de Janeiro, Brazil

iois.info

Add to calendar

Medical Materials

Agenda

Coming soon

11:15 AM

Duration 3mins Rio de Janeiro, Brazil

IL-6 Receptor Signaling Inhibition With Satralizumab▼ in Thyroid Eye Disease: Phase 3 SatraGO-1 and SatraGO-2 Trial Design

Coronel M, Ezra D, Collins A, Stan M, Haskova Z, Kuenzel T, Triyatni M, Idowu O

Ophthalmology | Thyroid eye disease

Add to calendar

08:12 PM

Duration 10mins Rio de Janeiro, Brazil

IL-6 Inhibition With Vamikibart: Phase 1 DOVETAIL Final Results and Phase 3 MEERKAT and SANDCAT Study Design

Suhler E, Steeples L, Khurana R, Muzaffar S, Lin P, Arrisi P, Elze M, MacGregor L, Stoilov I, Silverman D, Haskova Z, Mesquida M

Ophthalmology | Uveitic Macular Edema

Add to calendar

08:42 PM

Duration 7mins Rio de Janeiro, Brazil

Real-World Treatment Patterns and Ocular Morbidity in Patients With Uveitic Macular Edema Secondary to Noninfectious Uveitis in the United States

Quan Dong Nguyen, Lu Chen, Parul Dayal, Navdeep Pal, Ivo Stoilov, Marina Mesquida, Zdenka Haskova, Laura Steeples

Ophthalmology | Uveitic Macular Edema

Add to calendar

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.